Ignavine Explained

Class:μ-Opioid receptor positive allosteric modulator or agonist; Analgesic
Cas Number:1357-76-2
Pubchem:3035320
Chemspiderid:2299598
Chebi:138829
Synonyms:3,9,15-Trihydroxyhetisan-2-yl benzoate
Iupac Name:[(3''R'',4''R'',5''R'',11''S'',13''R'',16''R'',17''R'',18''R'')-4,13,18-trihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-3-yl] benzoate
C:27
H:31
N:1
O:5
Smiles:C[C@]12CN3[C@H]4[C@H]1C5(C3C6C[C@H]7C[C@@]5(C6(C4)[C@@H](C7=C)O)O)C[C@H]([C@@H]2O)OC(=O)C8=CC=CC=C8
Stdinchi:1S/C27H31NO5/c1-13-15-8-16-20-26-11-18(33-23(31)14-6-4-3-5-7-14)22(30)24(2)12-28(20)17(19(24)26)10-25(16,21(13)29)27(26,32)9-15/h3-7,15-22,29-30,32H,1,8-12H2,2H3/t15-,16?,17+,18+,19+,20?,21+,22-,24-,25?,26?,27-/m0/s1
Stdinchikey:FOIZZXKAYVIZQC-HBFXMWHYSA-N

Ignavine is a naturally occurring diterpene alkaloid found in Aconiti tuber.[1] [2] [3] [4] It has been reported to act as a μ-opioid receptor (MOR) positive allosteric modulator (PAM).[5] The drug potentiated responses to the selective MOR agonist DAMGO at low concentrations but inhibited DAMGO at high concentrations. Ignavine alone has been found to produce analgesic effects in animals, but with a biphasic dose–response curve.[6] Although described as a MOR PAM, other research suggests that ignavine is a ligand of the orthosteric site of the MOR and does not act as a PAM. Instead, it may be a MOR partial agonist. However, more research is necessary to clarify its MOR actions. Ignavine was first isolated by 1952 and its reported MOR PAM activity was first reported by 2016.

See also

Notes and References

  1. Remesic M, Hruby VJ, Porreca F, Lee YS . Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics . ACS Chem Neurosci . 8 . 6 . 1147–1158 . June 2017 . 28368571 . 5689070 . 10.1021/acschemneuro.7b00090 .
  2. Kaye AD, Cornett EM, Patil SS, Gennuso SA, Colontonio MM, Latimer DR, Kaye AJ, Urman RD, Vadivelu N . New opioid receptor modulators and agonists . Best Pract Res Clin Anaesthesiol . 32 . 2 . 125–136 . June 2018 . 30322454 . 10.1016/j.bpa.2018.06.009 .
  3. Badal S, Turfus S, Rajnarayanan R, Wilson-Clarke C, Sandiford SL . Analysis of natural product regulation of opioid receptors in the treatment of human disease . Pharmacol Ther . 184 . 51–80 . April 2018 . 29097308 . 10.1016/j.pharmthera.2017.10.021 .
  4. Saito H, Ueyama T, Naka N, Yagi J, Okamoto T . Pharmacological studies of ignavine, an aconitum alkaloid . Chem Pharm Bull (Tokyo) . 30 . 5 . 1844–1850 . May 1982 . 7116516 . 10.1248/cpb.30.1844 .
  5. Ohbuchi K, Miyagi C, Suzuki Y, Mizuhara Y, Mizuno K, Omiya Y, Yamamoto M, Warabi E, Sudo Y, Yokoyama A, Miyano K, Hirokawa T, Uezono Y . Ignavine: a novel allosteric modulator of the μ opioid receptor . Sci Rep . 6 . 31748 . August 2016 . 27530869 . 4987652 . 10.1038/srep31748 . 2016NatSR...631748O .
  6. Livingston KE, Traynor JR . Allostery at opioid receptors: modulation with small molecule ligands . Br J Pharmacol . 175 . 14 . 2846–2856 . July 2018 . 28419415 . 6016636 . 10.1111/bph.13823 .